Skip to main content
Log in

Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies

  • Article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Background

Thiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors. In this study, inhibition effects of some thiophene-based sulfonamides on human erythrocytes carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) were investigated. Thiophene-based sulfonamides used in this study showed potent inhibition effect on both isoenzymes at very small concentrations.

Materials and methods

We report on the purification of the carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) using affinity chromatography method. The inhibition effect of the thiophene-based sulfonamides was determined by IC50 and Ki parameters. A molecular docking study was performed for each molecule.

Results

Thiophene-based sulfonamides showed IC50 values of in the range of 69 nM to 70 µM against hCA-I, 23.4 nM to 1.405 µM against hCA-II. Ki values were in the range of 66.49 ± 17.15 nM to 234.99 ± 15.44 µM against hCA-I, 74.88 ± 20.65 nM to 38.04 ± 12.97 µM against hCA-II. Thiophene-based sulfonamides studied in this research showed noncompetitive inhibitory properties on both isoenzymes. To elucidate the mechanism of inhibition, a molecular docking study was performed for molecules 1 and 4 exhibiting a strong inhibitory effect on hCA-I and hCA-II. The compounds inhibit the enzymes by interacting out of catalytic active site. The sulfonamide and thiophene moiety played a significant role in the inhibition of the enzymes.

Conclusion

We hope that this study will contribute to the design of novel thiophene-based sulfonamide derived therapeutic agents that may be carbonic anhydrase inhibitors in inhibitor design studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov. 2017;12:61–88.

    Article  CAS  Google Scholar 

  2. Supuran CT. Special ıssue: sulfonamides. Molecules. 2017;22:1642.

    Article  Google Scholar 

  3. Capasso C, Supuran CT. Sulfa and trimethoprim-like drugs-antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors. J Enzyme Inhib Med Chem. 2014;29:379–87.

    Article  CAS  Google Scholar 

  4. Scozzafava A, Owa T, Mastrolorenzo A, Supuran CT. Anticancer and antiviral sulfonamides. Curr Med Chem. 2003;10:925–53.

    Article  CAS  Google Scholar 

  5. Monti SM, Supuran CT, De Simone G. Anticancer carbonic anhydrase inhibitors: a patent review (2008–2013). Expert Opin Ther Pat. 2013;23:737–49.

    Article  CAS  Google Scholar 

  6. Scozzafava A, Supuran CT, Carta F. Antiobesity carbonic anhydrase inhibitors: a literature and patent review. Expert Opin Ther Pat. 2013;23:725–35.

    Article  CAS  Google Scholar 

  7. Loubatières-Mariani MM. The discovery of hypoglycemic sulfonamides. J Soc Biol. 2007;201:121–5.

    Article  Google Scholar 

  8. Carta F, Supuran CT. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005–2013). Expert Opin Ther Pat. 2013;23:681–91.

    Article  CAS  Google Scholar 

  9. Carta F, Di Cesare Mannelli L, Pinard M, Ghelardini C, Scozzafava A, McKenna R, Supuran CT. A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. Bioorg Med Chem. 2015;23:1828–40.

    Article  CAS  Google Scholar 

  10. Carta F, Supuran CT, Scozzafava A. Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med. Chem. 2014;6:1149–65.

    Article  CAS  Google Scholar 

  11. Alterio V, Di Fiore A, D’Ambrosio K, Supuran CT, De Simone G. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev. 2012;112:4421–68.

    Article  CAS  Google Scholar 

  12. Supuran CT. Carbonic anhydrase inhibitors: an editorial. Expert Opin Ther Pat. 2013;23:677–9.

    Article  CAS  Google Scholar 

  13. Scozzafava A, Mastrolorenzo A, Supuran CT. Modulation of carbonic anhydrase activity and its applications in therapy. Expert Opın Ther Pat. 2004;14:667–702.

    Article  CAS  Google Scholar 

  14. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem. 2007;15:4336–50.

    Article  CAS  Google Scholar 

  15. Alım Z, Kilinc N, Sengul B, Beydemir S. Some anti-ınflammatory agents ınhibit esterase activities of human carbonic anhydrase ısoforms i and II: an in vitro study. Chem Biol Drug Des. 2015;86:857–63.

    Article  Google Scholar 

  16. Alım Z. 1H-indazole molecules reduced the activity of human erythrocytes carbonic anhydrase I and II isoenzymes. J Biochem Mol Toxicol. 2018;32:e22194.

    Article  Google Scholar 

  17. Koksal Z, Alım Z, Bayrak S, Gulcin I, Ozdemir H. Investigation of the effects of some sulfonamides on acetylcholinesterase and carbonic anhydrase enzymes. J Biochem Mol Toxicol. 2019;33(5):e22300.

    Article  Google Scholar 

  18. Wilbur KM, Anderson NG. Electrometric and colorimetric determination of carbonic anhydrase. J Biol Chem. 1948;176:147–54.

    CAS  PubMed  Google Scholar 

  19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976;72:248–54.

    Article  CAS  Google Scholar 

  20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5.

    Article  CAS  Google Scholar 

  21. Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem. 1967;242:4221–9.

    CAS  PubMed  Google Scholar 

  22. Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Am Chem Soc. 1934;56:658–66.

    Article  CAS  Google Scholar 

  23. Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2016; Impact, Schrödinger, LLC, New York, NY, 2016; Prime, Schrödinger, LLC, New York, NY. 2019.

  24. Kalin R, Koksal Z, Kalin P, Karaman M, Gulcin I, Ozdemir H. In vitro effects of standard antioxidants on lactoperoxidase enzyme—a molecular docking approach. J Biochem Mol Toxicol. 2020;34:e22421.

    Article  CAS  Google Scholar 

  25. Bayrak C, Taslimi P, Karaman HS, Gulcin I, Menzek A. The first synthesis, carbonic anhydrase inhibition and anticholinergic activities of some bromophenol derivatives with S including natural products. Bioorg Chem. 2019;85:128–39.

    Article  CAS  Google Scholar 

  26. SiteMap, Schrödinger, LLC, New York, NY. 2019.

  27. Bal S, Kaya R, Gök Y, Taslimi P, Aktaş A, Karaman M, et al. Novel 2-methylimidazolium salts: synthesis, characterization, molecular docking, and carbonic anhydrase and acetylcholinesterase inhibitory properties. Bioorg Chem. 2020;94:103468.

    Article  CAS  Google Scholar 

  28. LigPrep, Schrödinger, LLC, New York, NY. 2019.

  29. Taslimi P, Turkan F, Çetin A, Burhan H, Karaman M, Bildirici I, et al. Pyrazole[3,4-d]pyridazine derivatives: molecular docking and explore of acetylcholinesterase and carbonic anhydrase enzymes inhibitors as anticholinergics potentials. Bioorg Chem. 2019;92:103213.

    Article  CAS  Google Scholar 

  30. Glide, Schrödinger, LLC, New York, NY. 2019.

  31. Yigit B, Kaya R, Taslimi P, Isık Y, Karaman M, Yigit M, et al. Imidazolinium chloride salts bearing wingtip groups: synthesis, molecular docking and metabolic enzymes inhibition. J Mol Struct. 2019;1179:709–18.

    Article  CAS  Google Scholar 

  32. Turkan F, Cetin A, Taslimi P, Karaman HS, Gulcin I. Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives. Arch Pharm. 2019;352:e1800359.

    Article  Google Scholar 

  33. Induced Fit Docking protocol; Glide. Schrödinger, LLC, New York, NY, 2016. Schrödinger, LLC, New York, NY: Prime; 2019.

    Google Scholar 

  34. Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature. 2006;440:463–9.

    Article  CAS  Google Scholar 

  35. Shah R, Verma PK. Therapeutic importance of synthetic thiophene. Chem Cent J. 2018;12:137.

    Article  CAS  Google Scholar 

  36. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3–26.

    Article  CAS  Google Scholar 

  37. Karimov A, Orujova A, Taslimi P, Sadeghian N, Mammadov B, Karaman HS, et al. Novel functionally substituted esters based on sodium diethyldithiocarbamate derivatives: synthesis, characterization, biological activity and molecular docking studies. Bioorg Chem. 2020;99:103762.

    Article  CAS  Google Scholar 

  38. Singh P, Swain B, Thacker PS, Sigalapalli DK, Yadav PP, Angeli A, et al. Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids. Bioorg Chem. 2020;99:103839.

    Article  CAS  Google Scholar 

  39. Burmaoglu S, Akin-Kazancioglu E, Kaya R, Kazancioglu M, Karaman M, Algul O, et al. Synthesis of novel organohalogen chalcone derivatives and screening of their molecular docking study and some enzymes inhibition effects. J Mol Struct. 2020;1208:127868.

    Article  Google Scholar 

  40. D’Ambrosio K, Carradori S, Monti SM, Buonanno M, Secci D, Vullo D, et al. Out of the active site binding pocket for carbonic anhydrase inhibitors. Chem Commun. 2015;51:302–5.

    Article  Google Scholar 

  41. Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem. 2016;31:345–60.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Thank you to Atatürk University, Faculty of Science, Biochemistry Research Laboratory, which allows us to carry out studies to purify carbonic anhydrase isoenzymes.

Author information

Authors and Affiliations

Authors

Contributions

Z. Alim carried out purification and inhibition studies of hCA-I and hCA-II isoenzymes. Analysis of the results was done by Z. Alim and Z. Koksal. Molecular modeling studies were carried out by M. Karaman. The writing and language correction of the article were done by Z. Alim, Z. Koksal and M. Karaman.

Corresponding author

Correspondence to Zeynep Köksal.

Ethics declarations

Conflict of interest

The authors declare that no conflicts of interest exist.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 896 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alım, Z., Köksal, Z. & Karaman, M. Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies. Pharmacol. Rep 72, 1738–1748 (2020). https://doi.org/10.1007/s43440-020-00149-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43440-020-00149-4

Keywords

Navigation